Your browser doesn't support javascript.
loading
Severe Aplastic Anemia as First Manifestation of Classical Hodgkin Lymphoma.
Pedrosa, Cláudia L; Rosinha, Patrícia; Seabra, Patrícia; Ferreira, Gisela; Rosado, Cláudia; Regadas, Luísa; Casais, Cláudia; Coutinho, Jorge.
Affiliation
  • Pedrosa CL; Department of Clinical Hematology, Centro Hospitalar Universitário Do Porto, Porto, Portugal.
  • Rosinha P; Department of Internal Medicine, Centro Hospitalar Do Baixo Vouga, Aveiro, Portugal.
  • Seabra P; Department of Clinical Hematology, Centro Hospitalar Universitário Do Porto, Porto, Portugal.
  • Ferreira G; Department of Clinical Hematology, Centro Hospitalar Do Baixo Vouga, Aveiro, Portugal.
  • Rosado C; Department of Internal Medicine, Centro Hospitalar Do Baixo Vouga, Aveiro, Portugal.
  • Regadas L; Department of Clinical Hematology, Centro Hospitalar Universitário Do Porto, Porto, Portugal.
  • Casais C; Department of Clinical Hematology, Centro Hospitalar Universitário Do Porto, Porto, Portugal.
  • Coutinho J; Department of Clinical Hematology, Centro Hospitalar Universitário Do Porto, Porto, Portugal.
Case Rep Hematol ; 2021: 8876249, 2021.
Article de En | MEDLINE | ID: mdl-33628540
Autoimmune cytopenia, a known paraneoplastic complication of lymphoid neoplasms, may occur before, concurrently, at relapse, or even years after completion of lymphoma treatment. In the case of Hodgkin lymphoma (HL), it is thought that immune dysregulation, typical of this neoplasm, may be involved in the genesis of these manifestations. We report a 57-year-old male presenting with stage IIIA, International Prognostic Score (IPS) 4, nodular sclerosis HL, and severe AA (SAA) confirmed on the histologic exam of the bone marrow that showed severe marrow hypoplasia due to a decrease in the elements of the three cell linages with left shift of the myeloid maturation. Immunosuppression with steroids and cyclosporine A was started. Eltrombopag and G-CSF were also added. In spite of prompt initiation of immunosuppressive therapy, the patient presented an unfavorable outcome with progressive pancytopenia and severe acute cerebral hemorrhagic event. The patient died 59 days after admission. Although autoimmune disorders are described in HL, its concomitant diagnosis is extremely rare. Our case shows a rare instance of SAA as the first manifestation of HL.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Case Rep Hematol Année: 2021 Type de document: Article Pays d'affiliation: Portugal Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Case Rep Hematol Année: 2021 Type de document: Article Pays d'affiliation: Portugal Pays de publication: États-Unis d'Amérique